Fig. 3From: Adjuvant chemotherapy and survival among patients 70 years of age and younger with node-negative breast cancer and the 21-gene recurrence score of 26–30Breast cancer-specific and overall survival curves according to chemotherapy use in patients aged ≤ 70 years old with the RS 26–30 in the SEER 2004–2015 dataset (n = 5290). a Breast cancer-specific survival and b overall survivalBack to article page